[Cajanonic acid A derivative XJ-60 improves liver fibrosis in mice with non-alcoholic fatty liver disease by inhibiting the SP1/TGF-β/Smad3 signaling axis]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoGeng Z +8 more
europepmc +1 more source
[Exploration and application of nanotechnology in precision transarterial chemoembolization for hepatocellular carcinoma]. [PDF]
Zhonghua Gan Zang Bing Za ZhiKong JQ +5 more
europepmc +1 more source
[<i>MUTYH-APEX1</i> Axis Promotes Hepatocellular Carcinoma Progression and Therapeutic Resistance by Regulating Cell Cycle Proteins]. [PDF]
Sichuan Da Xue Xue Bao Yi Xue BanZhou Y +6 more
europepmc +1 more source
[<i>Yiqi Jiedu</i> Formula regulates immune microenvironment of liver cancer in mice by inhibiting overactivation of NF-κB signaling pathway]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoWang Z +5 more
europepmc +1 more source
[The Influence of Hepatitis B Virus on Sex Hormone Levels and Quality of Life in Female Hepatitis B Patients With Different Alanine Aminotransferase States]. [PDF]
Sichuan Da Xue Xue Bao Yi Xue BanGao P, Zhou W, Li J, Yao L.
europepmc +1 more source
[Research progress on liver transplantation therapy for hepatic metastases in gastroenteropancreatic neuroendocrine tumors]. [PDF]
Zhonghua Gan Zang Bing Za ZhiYang K, Zhang WQ, Chen CY, Jiang WT.
europepmc +1 more source
[Advances in research on metabolic associated fatty liver disease in 2025]. [PDF]
Zhonghua Gan Zang Bing Za ZhiRao HY, Zhao JM, Yu CH, Mi YQ, Wei L.
europepmc +1 more source
[A study on the efficacy and safety profile of transjugular intrahepatic portosystemic shunt received elderly patients with liver cirrhosis]. [PDF]
Zhonghua Gan Zang Bing Za ZhiCai ZH, Yin Q, Zhang F, Zhuge YZ.
europepmc +1 more source
[<i>Jiangzhi Quban</i> Recipe improves type 2 diabetes mellitus complicated with hyperlipidemia by multi-target regulation of the inflammation-metabolism network: network pharmacology analysis and clinical validation]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoLi Z +6 more
europepmc +1 more source